Airing on Thursday, May 7, 2015: One of the world’s biggest drug companies has moved to outsource the process of deciding who is allowed into its experimental drug trials.Johnson & Johnson is setting up what’s called a “compassionate use” panel to help it make these life & death decisions. Staying in the theme of pharmaceuticals,  Alexion announced it was buying Syngeva for $8.4 billion earlier this week. And it’s election day in the U.K. today. Inequality has been a key theme of the campaign. We’ll see how tax loopholes impact the results today.